Pharmaceutical giants AstraZeneca and Merck said Thursday they had agreed a multi-billion-dollar deal to jointly develop key cancer drugs.
"The strategic collaboration is expected to further increase the number of treatment options available to patients," British company AstraZeneca and its US peer said in a statement.
Merck will pay AstraZeneca up to $8.5 billion (7.2 billion euros) under the deal struck to develop and commercialise the drugs.
GMT 10:03 2018 Monday ,22 October
May to tell British parliament Brexit ‘95 percent’ settled, faces party mutinyGMT 08:03 2018 Monday ,22 January
Ecuador president calls Julian Assange a 'problem'GMT 16:47 2018 Thursday ,18 January
UK-France summit between May and Macron startsGMT 20:31 2018 Monday ,08 January
UK minister resigns after rejecting PM's reshuffleGMT 13:50 2018 Monday ,08 January
British PM begins reshuffle by naming new party chairmanMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor